Recurrent Pericarditis: New Treatment Shows Promise

To learn more about Cleveland Clinic’s Pericardial Disease Center, please visit https://cle.clinic/38W3i2j

Patients with pericarditis may be on various medications to prevent episodes from recurring. Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial that looked at a new medication (Rilonacept) vs. placebo for patients with pericarditis. He talks about the exciting results of this study and what this may mean for patients in the future.

Read the full article at Klein AL, Imazio M, Cremer P, et al., on behalf of the RHAPSODY Investigators. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med 2020; Nov 16: https://www.nejm.org/doi/full/10.1056...

▶Share this video with others:    • Recurrent Pericarditis: New Treatment...  

▶Subscribe to learn more about Cleveland Clinic: https://www.youtube.com/user/Clevelan...